000950 重药控股
已收盘 12-15 15:00:00
资讯
新帖
简况
异动快报：重药控股（000950）12月15日11点11分触及涨停板
证券之星 · 11:15
异动快报：重药控股（000950）12月15日11点11分触及涨停板
重药控股最新公告：目前经营情况正常不存在公司应披露而未披露的重大事项
证券之星 · 12-11
重药控股最新公告：目前经营情况正常不存在公司应披露而未披露的重大事项
12月11日重药控股（000950）龙虎榜数据：游资瑞鹤仙、上海松林路上榜
证券之星 · 12-11
12月11日重药控股（000950）龙虎榜数据：游资瑞鹤仙、上海松林路上榜
重药控股最新公告：参股子公司药友制药与辉瑞签订许可协议
证券之星 · 12-10
重药控股最新公告：参股子公司药友制药与辉瑞签订许可协议
重药控股：大健康子公司2024年实现盈利
证券之星 · 12-09
重药控股：大健康子公司2024年实现盈利
重药控股（000950）披露拟召开临时股东会审议前三季度利润分配预案，12月4日股价上涨0.18%
证券之星 · 12-04
重药控股（000950）披露拟召开临时股东会审议前三季度利润分配预案，12月4日股价上涨0.18%
重药控股：12月4日接受机构调研，东吴证券、易方达参与
证券之星 · 12-04
重药控股：12月4日接受机构调研，东吴证券、易方达参与
重药控股（000950）披露回购股份进展公告，12月1日股价上涨0.38%
证券之星 · 12-01
重药控股（000950）披露回购股份进展公告，12月1日股价上涨0.38%
重药控股最新公告：下属22家子公司补缴税款及滞纳金总计4430.26万元
证券之星 · 11-27
重药控股最新公告：下属22家子公司补缴税款及滞纳金总计4430.26万元
重药控股：销售玛巴洛沙韦片、奥司他韦等流感药品
证券之星 · 11-27
重药控股：销售玛巴洛沙韦片、奥司他韦等流感药品
股市必读：重药控股（000950）11月7日董秘有最新回复
证券之星 · 11-10
股市必读：重药控股（000950）11月7日董秘有最新回复
重药控股：米拉贝隆缓释片获药品注册证书
证券之星 · 11-07
重药控股：米拉贝隆缓释片获药品注册证书
重药控股（000950）披露回购股份进展公告，11月03日股价上涨0.74%
证券之星 · 11-03
重药控股（000950）披露回购股份进展公告，11月03日股价上涨0.74%
重药控股(000950)9月30日股东户数4.2万户，较上期减少4.05%
证券之星 · 10-28
重药控股(000950)9月30日股东户数4.2万户，较上期减少4.05%
股市必读：重药控股（000950）10月27日董秘有最新回复
证券之星 · 10-28
股市必读：重药控股（000950）10月27日董秘有最新回复
重药控股（000950）披露下属子公司调整担保额度议案获股东会通过，10月23日股价上涨0.19%
证券之星 · 10-23
重药控股（000950）披露下属子公司调整担保额度议案获股东会通过，10月23日股价上涨0.19%
股市必读：重药控股（000950）10月22日董秘有最新回复
证券之星 · 10-23
股市必读：重药控股（000950）10月22日董秘有最新回复
股市必读：重药控股（000950）10月21日董秘有最新回复
证券之星 · 10-22
股市必读：重药控股（000950）10月21日董秘有最新回复
重药控股（000950）披露召开2025年第四次临时股东会提示性公告，10月17日股价下跌0.95%
证券之星 · 10-17
重药控股（000950）披露召开2025年第四次临时股东会提示性公告，10月17日股价下跌0.95%
股市必读：重药控股（000950）预计2025年1-9月每股收益盈利:0.2元至0.23元
证券之星 · 10-13
股市必读：重药控股（000950）预计2025年1-9月每股收益盈利:0.2元至0.23元
暂无数据
公司概况
公司名称：
重药控股股份有限公司
所属行业：
批发业
上市日期：
1999-09-16
主营业务：
重药控股股份有限公司的主营业务是医药商业、仓储物流、医药工业和研发等业务。公司的主要产品是药品类、医疗器械类、其他。
发行价格：
4.63
{"stockData":{"symbol":"000950","market":"SZ","secType":"STK","nameCN":"重药控股","latestPrice":6.79,"timestamp":1765782210000,"preClose":6.17,"halted":0,"volume":212716738,"delay":0,"changeRate":0.1005,"floatShares":1728000000,"shares":1728000000,"eps":0.2169,"marketStatus":"已收盘","change":0.62,"latestTime":"12-15 15:00:00","open":6.05,"high":6.79,"low":5.82,"amount":1350000000,"amplitude":0.1572,"askPrice":0,"askSize":0,"bidPrice":6.79,"bidSize":102993,"shortable":0,"etf":0,"ttmEps":0.2169,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.17,"symbolType":"stock","openAndCloseTimeList":[[1765762200000,1765769400000],[1765774800000,1765782000000]],"highLimit":6.79,"lowLimit":5.55,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1728184696,"isCdr":false,"pbRate":0.92,"roa":"--","peRate":31.304749,"roe":"3.35%","epsLYR":0.16,"committee":0,"marketValue":11734000000,"turnoverRate":0.1231,"status":0,"floatMarketCap":11734000000},"requestUrl":"/m/hq/s/000950/tweets","defaultTab":"tweets","newsList":[{"id":"2591915256","title":"异动快报：重药控股（000950）12月15日11点11分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2591915256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591915256?lang=zh_cn&edition=full","pubTime":"2025-12-15 11:15","pubTimestamp":1765768524,"startTime":"0","endTime":"0","summary":"证券之星12月15日盘中消息，11点11分重药控股触及涨停板。其所属行业医药商业目前上涨。该股为重庆国企改革，医疗耗材供应链SPD，医药商业概念热股，当日重庆国企改革概念上涨1.73%，医疗耗材供应链SPD概念上涨1.62%，医药商业概念上涨1.15%。12月12日的资金流向数据方面，主力资金净流出1.5亿元，占总成交额9.67%，游资资金净流入8378.63万元，占总成交额5.39%，散户资金净流入6669.85万元，占总成交额4.29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500007981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"gpt_icon":0},{"id":"2590594408","title":"重药控股最新公告：目前经营情况正常不存在公司应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2590594408","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590594408?lang=zh_cn&edition=full","pubTime":"2025-12-11 18:02","pubTimestamp":1765447329,"startTime":"0","endTime":"0","summary":"重药控股(000950.SZ)公告称，公司股票于2025年12月10日、12月11日连续两个交易日收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动情况。经核实，公司前期披露的信息不存在需要更正、补充之处，近期公司经营情况正常，内外部经营环境未发生重大变化。公司控股股东及实际控制人不存在有关公司的应披露而未披露的重大事项或正处于筹划中的重大事项。股票交易异常波动期间，公司控股股东及实际控制人不存在买卖公司股票的情形。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100029993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"gpt_icon":0},{"id":"2590529594","title":"12月11日重药控股（000950）龙虎榜数据：游资瑞鹤仙、上海松林路上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2590529594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590529594?lang=zh_cn&edition=full","pubTime":"2025-12-11 17:56","pubTimestamp":1765446982,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年12月11日公布的交易公开信息显示，重药控股因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年12月11日收盘，重药控股报收于6.45元，上涨10.07%，已连续涨停2天，换手率1.81%，成交量31.27万手，成交额2.02亿元。从龙虎榜公布的三日买卖数据来看，瑞鹤仙、上海松林路等知名游资榜上有名。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100029389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"gpt_icon":0},{"id":"2590158116","title":"重药控股最新公告：参股子公司药友制药与辉瑞签订许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2590158116","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590158116?lang=zh_cn&edition=full","pubTime":"2025-12-10 19:50","pubTimestamp":1765367412,"startTime":"0","endTime":"0","summary":"重药控股(000950.SZ)公告称，公司参股子公司药友制药与辉瑞签订许可协议，药友制药授予辉瑞在全球范围内及人类、动物所有适应症的治疗、诊断及预防领域独家开发、使用、生产及商业化口服小分子胰高血糖素样肽-1受体（GLP-1R）激动剂（包括YP05002）及含有该活性成分的产品。就本次许可，药友制药将有权依约获得（其中包括）不可退还的首付款 15,000万美元及基于许可产品临床、商业化进展获得开发里程碑付款至多35,000万美元。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000035059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01477","BK0071","BK0250","000950","BK1191","BK1574"],"gpt_icon":0},{"id":"2590936053","title":"重药控股：大健康子公司2024年实现盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2590936053","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590936053?lang=zh_cn&edition=full","pubTime":"2025-12-09 09:01","pubTimestamp":1765242060,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)12月08日在投资者关系平台上答复投资者关心的问题。投资者提问：重药大健康成立以来实现过盈利吗重药控股回复：重庆医药集团大健康科技有限公司是公司下属一家全资子公司，目前其聚焦医学营养、院线医美、健康保健三大核心业务板块并处于战略孵化关键期，其在2024年度实现了盈利；后续将深耕细作、精准布局，着力打造医疗专业属性与多元消费场景深度融合的大健康产业生态，持续推进业务落地与模式创新。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900004760.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0250","BK0071"],"gpt_icon":0},{"id":"2588880925","title":"重药控股（000950）披露拟召开临时股东会审议前三季度利润分配预案，12月4日股价上涨0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588880925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588880925?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:19","pubTimestamp":1764857961,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘，重药控股报收于5.47元，较前一交易日上涨0.18%，最新总市值为94.53亿元。该股当日开盘5.45元，最高5.49元，最低5.38元，成交额达1.4亿元，换手率为1.49%。公司近日发布公告称，将召开2025年第五次临时股东会，会议由董事会召集，现场会议定于2025年12月22日14:30在重庆市渝北区金石大道303号公司会议室举行。股权登记日为2025年12月17日，会议将审议《2025年前三季度利润分配预案的议案》。公告明确，中小投资者表决将单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400039627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"gpt_icon":0},{"id":"2588891338","title":"重药控股：12月4日接受机构调研，东吴证券、易方达参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2588891338","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588891338?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:02","pubTimestamp":1764849770,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年12月4日重药控股发布公告称公司于2025年12月4日接受机构调研，东吴证券、易方达参与。截至 2025 年 9 月末，公司拥有的零售药房已覆盖全国 22个省、直辖市及自治区，社区健康药房 832 家，DTP处方药房210家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400034919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0276","BK0188","000950","BK0183","BK0028","BK0250","601555","BK0009","BK0071"],"gpt_icon":0},{"id":"2588755917","title":"重药控股（000950）披露回购股份进展公告，12月1日股价上涨0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588755917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588755917?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:24","pubTimestamp":1764599054,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘，重药控股报收于5.29元，较前一交易日上涨0.38%，最新总市值为91.42亿元。该股当日开盘5.27元，最高5.32元，最低5.26元，成交额达7650.67万元，换手率为0.84%。公司近日发布公告称，重药控股股份有限公司于2025年7月10日和7月28日审议通过回购股份议案，拟使用自有资金及专项贷款通过集中竞价方式回购A股股份，用于减少注册资本。回购符合相关法规及方案要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100036831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"gpt_icon":0},{"id":"2586247084","title":"重药控股最新公告：下属22家子公司补缴税款及滞纳金总计4430.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586247084","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586247084?lang=zh_cn&edition=full","pubTime":"2025-11-27 20:19","pubTimestamp":1764245966,"startTime":"0","endTime":"0","summary":"重药控股(000950.SZ)公告称，公司下属22家子公司根据各自主管税务部门的通知，需补缴前期所享受的西部大开发企业所得税优惠税款及滞纳金总计4430.26万元。目前，上述税款及滞纳金已全部缴纳完毕，主管税务部门未对该事项予以处罚。补缴税款及滞纳金将计入2025年当期损益，对公司2025年度归属于上市公司股东的净利润的具体影响最终以公司2025年度经审计的财务报表为准。本次补缴税款事项不会影响公司的正常经营。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700034346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"gpt_icon":0},{"id":"2586060291","title":"重药控股：销售玛巴洛沙韦片、奥司他韦等流感药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2586060291","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586060291?lang=zh_cn&edition=full","pubTime":"2025-11-27 08:45","pubTimestamp":1764204314,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)11月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司生产或者销售的有什么治疗甲流的药物？重药控股回复：公司有销售玛巴洛沙韦片、奥司他韦、抗生素系列等多种可用于治疗感冒及流感的药品。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700004269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"gpt_icon":0},{"id":"2582818455","title":"股市必读：重药控股（000950）11月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582818455","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582818455?lang=zh_cn&edition=full","pubTime":"2025-11-10 02:13","pubTimestamp":1762711993,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，重药控股报收于5.52元，上涨1.66%，换手率2.1%，成交量36.22万手，成交额2.0亿元。此外，公司于2025年9月11日在巨潮资讯网披露了《关于子公司药物获临床试验批准的公告》，控股子公司研发的盐酸普拉格雷片获药物临床试验批准，截至目前III期临床已启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000000866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"gpt_icon":0},{"id":"2581407095","title":"重药控股：米拉贝隆缓释片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2581407095","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581407095?lang=zh_cn&edition=full","pubTime":"2025-11-07 17:00","pubTimestamp":1762506039,"startTime":"0","endTime":"0","summary":"重药控股回复：公司于2025年1月10日在巨潮资讯网披露了《关于控股子公司获得药品注册证书的公告》，控股子公司研发的米拉贝隆缓释片获得国家药监局签发的《药品注册证书》，至此公司共有4个产品取得了《药品注册证书》。此外，公司于2025年9月11日在巨潮资讯网披露了《关于子公司药物获临床试验批准的公告》，控股子公司研发的盐酸普拉格雷片获药物临床试验批准，截至目前III期临床已启动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700026318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"gpt_icon":0},{"id":"2580288214","title":"重药控股（000950）披露回购股份进展公告，11月03日股价上涨0.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580288214","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580288214?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:47","pubTimestamp":1762181238,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，重药控股报收于5.41元，较前一交易日上涨0.74%，最新总市值为93.49亿元。该股当日开盘5.39元，最高5.42元，最低5.36元，成交额达9793.19万元，换手率为1.05%。公司近日发布公告称，重药控股股份有限公司于2025年7月10日、7月28日召开董事会及临时股东会，审议通过回购股份议案，拟使用自有资金及专项贷款通过集中竞价方式回购A股股份，用于减少注册资本。后续将根据市场情况推进回购，并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300036381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"gpt_icon":0},{"id":"2578936208","title":"重药控股(000950)9月30日股东户数4.2万户，较上期减少4.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578936208","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578936208?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:28","pubTimestamp":1761643694,"startTime":"0","endTime":"0","summary":"证券之星消息，近日重药控股披露，截至2025年9月30日公司股东户数为4.2万户，较6月30日减少1773.0户，减幅为4.05%。在医药商业行业个股中，重药控股股东户数高于行业平均水平，截至9月30日，医药商业行业平均股东户数为3.96万户。从股价来看，2025年6月30日至2025年9月30日，重药控股区间涨幅为2.2%，在此期间股东户数减少1773.0户，减幅为4.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"gpt_icon":0},{"id":"2578914624","title":"股市必读：重药控股（000950）10月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2578914624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578914624?lang=zh_cn&edition=full","pubTime":"2025-10-28 01:56","pubTimestamp":1761587772,"startTime":"0","endTime":"0","summary":"截至2025年10月27日收盘，重药控股报收于5.33元，下跌0.56%，换手率1.03%，成交量17.84万手，成交额9536.73万元。董秘最新回复投资者： 公司半年报中，25亿预付款中有多少预收款作保障董秘： 公司财务情况请见公司在巨潮资讯网披露的定期报告。当日关注点来自交易信息汇总：10月27日主力资金净流出1603.07万元，显示主力短期减持动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800001772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"gpt_icon":0},{"id":"2577374675","title":"重药控股（000950）披露下属子公司调整担保额度议案获股东会通过，10月23日股价上涨0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577374675","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577374675?lang=zh_cn&edition=full","pubTime":"2025-10-23 17:19","pubTimestamp":1761211159,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，重药控股报收于5.39元，较前一交易日上涨0.19%，最新总市值为93.15亿元。公司近日发布公告称，重药控股股份有限公司于2025年10月22日召开2025年第四次临时股东会，会议审议通过《关于下属子公司调整担保额度的议案》。出席本次会议的股东及代理人共329人，代表股份1,019,935,266股，占公司有表决权股份总数的59.5486%。表决结果显示，同意股份数占出席会议有效表决权股份总数的99.6407%，反对占比0.3044%，弃权占比0.0549%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300026804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"gpt_icon":0},{"id":"2577631398","title":"股市必读：重药控股（000950）10月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577631398","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577631398?lang=zh_cn&edition=full","pubTime":"2025-10-23 03:10","pubTimestamp":1761160221,"startTime":"0","endTime":"0","summary":"截至2025年10月22日收盘，重药控股报收于5.38元，上涨1.13%，换手率1.22%，成交量21.12万手，成交额1.13亿元。表决结果显示，同意股份数占出席本次股东会有表决权股份总数的99.6407%，反对占0.3044%，弃权占0.0549%。2025年第四次临时股东会决议公告重药控股股份有限公司于2025年10月22日召开2025年第四次临时股东会，会议由董事会召集，董事长袁泉主持，采用现场与网络投票结合方式召开。北京市竞天公诚律师事务所出具法律意见书，认为本次股东会合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300001950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"gpt_icon":0},{"id":"2577803762","title":"股市必读：重药控股（000950）10月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577803762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577803762?lang=zh_cn&edition=full","pubTime":"2025-10-22 01:55","pubTimestamp":1761069310,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘，重药控股报收于5.32元，上涨1.14%，换手率1.15%，成交量19.84万手，成交额1.05亿元。董秘最新回复投资者： 公司挂名董监高对公司的经营价值如何评估，高管人员能否压减1/3以上董秘： 感谢您的关注与建议！当日关注点来自交易信息汇总：10月21日主力资金净流出1352.65万元，散户资金净流入1975.36万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200001092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"gpt_icon":0},{"id":"2576059198","title":"重药控股（000950）披露召开2025年第四次临时股东会提示性公告，10月17日股价下跌0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576059198","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576059198?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:25","pubTimestamp":1760711116,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，重药控股报收于5.24元，较前一交易日下跌0.95%，最新总市值为90.56亿元。该股当日开盘5.28元，最高5.32元，最低5.24元，成交额达1.01亿元，换手率为1.11%。公司近日发布公告称，重药控股股份有限公司将于2025年10月22日14:30召开2025年第四次临时股东会，会议采取现场与网络投票相结合方式，网络投票时间为当日9:15-15:00。股东可于2025年10月21日通过现场、信函、电子邮件或传真方式登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700038457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"gpt_icon":0},{"id":"2575146084","title":"股市必读：重药控股（000950）预计2025年1-9月每股收益盈利:0.2元至0.23元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575146084","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575146084?lang=zh_cn&edition=full","pubTime":"2025-10-13 02:43","pubTimestamp":1760294589,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，重药控股报收于5.17元，上涨0.19%，换手率0.89%，成交量15.36万手，成交额7936.9万元。来自业绩披露要点：重药控股预计2025年前三季度归母净利润为3.58亿元至4亿元，同比增长22.51%至36.88%。业绩披露要点业绩预告重药控股发布业绩预告，预计2025年1-9月每股收益盈利0.2元至0.23元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300000916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765792197424,"stockEarnings":[{"period":"1week","weight":0.13},{"period":"1month","weight":0.0979},{"period":"3month","weight":0.1708},{"period":"6month","weight":0.2318},{"period":"1year","weight":0.0077},{"period":"ytd","weight":0.1539}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重药控股股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"42036人(较上一季度减少4.05%)","perCapita":"41112股","listingDate":"1999-09-16","address":"重庆市渝北区金石大道303号","registeredCapital":"172818万元","survey":" 重药控股股份有限公司的主营业务是医药商业、仓储物流、医药工业和研发等业务。公司的主要产品是药品类、医疗器械类、其他。","listedPrice":4.63},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"重药控股,000950,重药控股股票,重药控股股票老虎,重药控股股票老虎国际,重药控股行情,重药控股股票行情,重药控股股价,重药控股股市,重药控股股票价格,重药控股股票交易,重药控股股票购买,重药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}